These results are consistent with our previous findings that D-4F treatment of T1DM rats decreases MMP9 and proinflammatory mediators TNFα, TLR-4 and increases anti-inflammatory M2-macrophage polarization (45). Here, TLR4 is linked to type 1 diabetes mellitus.